Intellia Therapeutics (NTLA)

Intellia Therapeutics (NTLA) – Corporate News

Mar 18, 2024 07:36 AM Intellia Therapeutics (NTLA) doses first patient in Phase 3 MAGNITUDE Study of NTLA-2001
Feb 15, 2024 07:34 AM Intellia Therapeutics (NTLA) and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
Jan 31, 2024 05:00 PM
Jan 4, 2024 04:02 PM
Nov 24, 2023 09:34 AM
Nov 14, 2023 07:31 AM
Nov 2, 2023 07:03 AM
Oct 18, 2023 07:02 AM
Oct 13, 2023 08:40 AM
Oct 3, 2023 07:02 AM
Jun 12, 2023 05:24 AM
Jun 5, 2023 04:02 PM
May 31, 2023 07:41 AM
Apr 17, 2023 04:01 PM
Mar 24, 2023 07:06 AM
Mar 21, 2023 07:32 AM
Mar 2, 2023 07:01 AM
Jan 11, 2023 07:30 AM
Dec 1, 2022 07:30 AM
Sep 16, 2022 07:16 AM
Sep 16, 2022 07:02 AM
Sep 1, 2022 04:01 PM
Jun 24, 2022 07:31 AM
May 2, 2022 04:01 PM
May 2, 2022 07:31 AM
Mar 9, 2022 04:01 PM
Feb 28, 2022 04:02 PM
Feb 23, 2022 08:06 AM
Feb 15, 2022 07:39 AM
Feb 3, 2022 07:30 AM
Jan 6, 2022 07:46 AM
Jan 5, 2022 07:31 AM
Nov 22, 2021 07:32 AM
Nov 4, 2021 07:52 AM
Oct 21, 2021 07:30 AM
Oct 20, 2021 07:31 AM
Oct 13, 2021 07:02 AM
Sep 16, 2021 07:31 AM
Jun 30, 2021 05:00 AM
Jun 28, 2021 04:02 PM
Jun 28, 2021 06:08 AM
Jun 22, 2021 07:01 AM
Jun 17, 2021 04:23 PM
Jun 4, 2021 07:31 AM
May 6, 2021 07:40 AM
Mar 30, 2021 07:32 AM
Mar 10, 2021 07:31 AM
Feb 25, 2021 07:39 AM
Dec 2, 2020 06:04 AM
Nov 11, 2020 07:34 AM